Better adherence with once-daily antiretroviral regimens: a meta-analysis.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Infectious Diseases

• Publication date

  2009-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/596482PMID 19140758PMCID PMC2708315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance

  2008cited by this paper
• Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression

  2008cited by this paper
• Adherence with lopinavir/ritonavir (LPV/r) tablet and SoftGel (SGC) capsule based antiretroviral regimens and predictors of early treatment compliance

  2008cited by this paper
• Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study

  2007cited by this paper
• A Lopinavir/Ritonavir-Based Once-Daily Regimen Results in Better Compliance and Is Non-inferior to a Twice-Daily Regimen Through 96 Weeks

  2007cited by this paper
• Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis.

  2007cited by this paper
• Durability of Adherence to Antiretroviral Therapy on Initial and Subsequent Regimens

  2006cited by this paper
• Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

  2006cited by this paper
• Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load: A Meta-Analytic Review of Randomized Controlled Trials

  2006cited by this paper
• Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

  2006cited by this paper
• An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

  2006cited by this paper
• Pilot Study of Once-Daily Simplification Therapy with Abacavir/Lamivudine/Zidovudine and Efavirenz for Treatment of HIV-1 Infection

  2006cited by this paper
• Abacavir and Lamivudine Fixed-Dose Combination Tablet Once Daily Compared With Abacavir and Lamivudine Twice Daily in HIV-Infected Patients Over 48 Weeks (ESS30008, SEAL)

  2005cited by this paper
• Estimating the mean and variance from the median, range, and the size of a sample

  2005cited by this paper
• Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged‐release capsules

  2005cited by this paper
• Perspectives on Adherence and Simplicity for HIV-Infected Patients on Antiretroviral Therapy: Self-Report of the Relative Importance of Multiple Attributes of Highly Active Antiretroviral Therapy (HAART) Regimens in Predicting Adherence

  2004cited by this paper
• Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.

  2004cited by this paper
• Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.

  2004cited by this paper
• A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV

  2004cited by this paper
• Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 109 cells/L

  2003cited by this paper
• The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

  2002cited by this paper
• Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

  2001cited by this paper
• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

  2000cited by this paper

• Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimens

  2025cites this paper
• The CanCURE Survey: Gender-Based Differences in HIV Cure Research Priorities

  2025cites this paper
• Understanding Perceived Pill Burden in Older Adults with HIV: Exploring Clinical and Demographic Determinants

  2025cites this paper
• Real-World Persistence in Adults with HIV and Mental Health or Substance Use Disorders After Restarting Antiretroviral Therapy in the United States

  2025cites this paper
• A cross-sectional study of the factors influencing adherence to antiretroviral therapy among adults with human immunodeficiency virus infection in a tertiary care hospital in Puducherry, India

  2024cites this paper
• A Comparative Study on Antiretroviral Therapy (ART) Adherence Among the Tribal and Non-tribal Populations Living With HIV/AIDS in Ranchi, India

  2024cites this paper
• Limitations to Treatment Safety and Efficacy Adherence to the Continuum of Care

  2023cites this paper
• Adherence to oral antiretroviral therapy in Canada, 2010–2020

  2023cites this paper
• Factors associated with adherence and viral suppression among patients on second-line antiretroviral therapy in an urban HIV program in Kenya

  2023cites this paper
• Synergist effect of antiretroviral therapy adherence and viral load suppression on quality of life of people with HIV/AIDS.

  2023cites this paper
• Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program

  2023cites this paper
• Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review

  2023cites this paper
• Special Collection: A pioneer in antiviral drug discovery and development: Commemorating John Martin-Original Article

  2022cites this paper
• The transformation of HIV therapy: One pill once a day

  2022cites this paper
• Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)

  2022cites this paper
• Limitations to Treatment Safety and Efficacy Adherence to the Continuum of Care

  2022cites this paper
• Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)

  2022cites this paper
• [HIV drug resistance: past and current trends].

  2022cites this paper
• Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis

  2022cites this paper
• Effects of raltegravir formulation change on medication adherence and medication errors.

  2022cites this paper
• EVG/COBI/FTC/TAF Bioequivalence Comparing Whole Tablets with Tablets Dissolved in Tap Water

  2022cites this paper
• Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017

  2021cites this paper
• Limitations to Treatment Safety and Efficacy

  2021cites this paper
• Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial

  2021cites this paper
• Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication

  2021cites this paper
• Redefining therapeutic success in HIV patients: an expert view

  2021cites this paper
• Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen.

  2021cites this paper
• Key Summary of Adherence to the Continuum of Care

  2020cites this paper
• Higher medication complexity in persons with HIV is associated with lower tenofovir diphosphate in dried blood spots

  2020cites this paper
• Overview of systematic reviews on strategies to improve treatment initiation, adherence to antiretroviral therapy and retention in care for people living with HIV: part 1

  2020cites this paper
• Impact of mail order pharmacy use and travel time to pharmacy on viral suppression among people living with HIV

  2020cites this paper
• Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial.

  2020cites this paper
• Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017

  2020cites this paper
• Anti-retroviral therapy failure in HIV-1 infected pregnant women and its associated risk of HIV transmission

  2020cites this paper
• Decreasing time to antiretroviral therapy initiation after HIV diagnosis in a clinic‐based observational cohort study in four African countries

  2020cites this paper
• Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals

  2020cites this paper
• Quantificação simultânea de efavirenz, lamivudina e fumarato de tenofovir desoproxila em comprimidos de dose fixa combinada por cromatografia a líquido de alta eficiência

  2020cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

  2020cites this paper
• Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin.

  2019cites this paper
• Adherence to Hiv treatment regimens: systematic literature review and meta-analysis

  2019cites this paper
• Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus

  2019cites this paper
• Adherence to HIV treatment regimens: systematic literature review and meta-analysis

  2019cites this paper
• Early assessment of antiretroviral efficacy is critical to prevent the emergence of resistance mutations in HIV-tuberculosis coinfected patients: a substudy of the CARINEMO-ANRS12146 trial

  2019cites this paper
• Management of Virologic Failure and Human Immunodeficiency Virus Drug Resistance.

  2019cites this paper
• A triaged real-time alert intervention to improve antiretroviral therapy adherence among young African American men who have sex with men living with HIV: focus group findings

  2019cites this paper
• Treatment Adherence, Meaning in Life and Affects in Quality of Life of HIV/AIDS Patients

  2019cites this paper
• Deprescribing of non-antiretroviral therapy in HIV-infected patients

  2019cites this paper
• Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy.

  2019cites this paper
• Pediatric Antiretroviral Therapy.

  2019cites this paper
• Desimplification to multi-tablet antiretroviral regimens in human immunodeficiency virus-type 1 infected adults: A cohort study

  2019cites this paper
• Adherence to Hiv treatment regimens: systematic literature review and meta-analysis

  2019cites this paper
• Adherence to Hiv treatment regimens: systematic literature review and meta-analysis

  2019cites this paper
• A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs

  2018cites this paper
• Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients

  2018cites this paper
• HIV virologic response better with single-tablet once daily regimens compared to multiple-tablet daily regimens

  2018cites this paper
• Comparison of Interventions to Improve Long-Term Medication Adherence Across Different Clinical Conditions: A Systematic Review With Network Meta-Analysis

  2018cites this paper
• Adherence to antiretroviral therapy, stigma and behavioral risk factors in HIV-infected adolescents in Asia

  2018cites this paper
• Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice

  2018cites this paper
• Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain

  2018cites this paper
• Long term adherence to antiretroviral therapy in a South African cohort.

  2018cites this paper
• Antiretroviral pill count and clinical outcomes in treatment‐naïve patients with HIV infection

  2018cites this paper
• Next generation fixed dose combination pharmacotherapies for treating HIV

  2018cites this paper
• Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial

  2018cites this paper
• Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)

  2018cites this paper
• 3 Social Determinants of HIV Health Care : A Tale of Two Cities

  2018cites this paper
• Durability of dolutegravir plus boosted darunavir as salvage or simplification of salvage regimens in HIV-1 infected, highly treatment-experienced subjects

  2018cites this paper
• Accumulated pre-switch resistance to more recently introduced one-pill-once-a-day antiretroviral regimens impacts HIV-1 virologic outcome.

  2018cites this paper
• Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis

  2017cites this paper
• Financial Barriers and Lapses in Treatment and Care of HIV-Infected Adults in a Southern State in the United States

  2017cites this paper
• Odds of Viral Suppression by Single‐Tablet Regimens, Multiple‐Tablet Regimens, and Adherence Level in HIV/AIDS Patients Receiving Antiretroviral Therapy

  2017cites this paper
• Impact de l’arrêt de médicaments antirétroviraux concernés par la résistance virale à la lumière des données de l’algorithme d’interprétation le plus récent

  2017cites this paper
• Clinical Outcomes Associated with Single Tablet Regimens: Relationship between Antiretroviral Therapy Pill Burden and Control of Concomitant Comorbidities among HIV-Infected Patients

  2017cites this paper
• Co-administration of elvitegravir/cobicistat/tenofovir disoproxil fumarate/emtricitabine and atazanavir in treatment-experienced HIV patients

  2017cites this paper
• Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression

  2017cites this paper
• Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.

  2017cites this paper
• Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets

  2017cites this paper
• Diary study of adherence to antiretroviral therapy in people living with HIV

  2017cites this paper
• Barriers to HIV Medication Adherence as a Function of Regimen Simplification

  2017cites this paper
• The Role of Financial Incentives Along the Antiretroviral Therapy Adherence Continuum: A Qualitative Sub-study of the HPTN 065 (TLC-Plus) Study

  2017cites this paper
• Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study

  2017cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV

  2017cites this paper
• Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Outpatient HIV care in the Netherlands

  2017cites this paper
• Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France

  2017cites this paper
• [Treating HIV disease: back to the patient?]

  2016cites this paper
• Simplification of HAART therapy on ambulatory HIV patients in Malaysia:a randomized controlled trial

  2016cites this paper
• Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996–2013

  2016cites this paper
• Cost-effectiveness of once-daily versus twice-daily regimens in the treatment of HIV infection in sub-Saharan Africa: a probabilistic decision model

  2016cites this paper
• The Impact of Alcohol use during Seemingly Suppressive Antiretroviral Therapy: Risk of Blips and Rebounds

  2016cites this paper
• What is the effect of pill burden on adherence to HIV antiretroviral therapy?

  2016cites this paper
• The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients

  2016cites this paper
• Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era?

  2016cites this paper
• Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana

  2016cites this paper
• Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks.

  2016cites this paper
• Model of care for HIV infection in Ireland

  2016cites this paper
• Improving and validating data-driven genotypic interpretation systems for the selection of antiretroviral therapies

  2016cites this paper
• Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia

  2016cites this paper
• Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy

  2016cites this paper
• Analysis of antiretroviral therapy modification in routine clinical practice in the management of HIV infection

  2016cites this paper
• Generic antiretroviral drugs and HIV care: An economic review.

  2016cites this paper